Literature DB >> 11880717

Current understanding of neuroprotection in glaucoma.

Francine B Wein1, Leonard A Levin.   

Abstract

The most common optic neuropathy is glaucomatous optic neuropathy, distinguished by a distinctive and progressive excavation of the optic nerve head without significant pallor of the remaining neuroretinal rim. Neuroprotection is a novel strategy for treating disorders that affect the nervous system by preventing death of neurons. In glaucomatous optic neuropathy, the neurons that die are retinal ganglion cells. This article reviews the recent basic science relevant to neuroprotection, particularly with respect to retinal ganglion cell death in glaucomatous and other optic neuropathies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11880717     DOI: 10.1097/00055735-200204000-00002

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  13 in total

Review 1.  Neuroprotection in glaucoma: drug-based approaches.

Authors:  William Cheung; Li Guo; M Francesca Cordeiro
Journal:  Optom Vis Sci       Date:  2008-06       Impact factor: 1.973

2.  Sulbutiamine counteracts trophic factor deprivation induced apoptotic cell death in transformed retinal ganglion cells.

Authors:  Kui Dong Kang; Aman Shah Abdul Majid; Kyung-A Kim; Kyungsu Kang; Hong Ryul Ahn; Chu Won Nho; Sang Hoon Jung
Journal:  Neurochem Res       Date:  2010-08-31       Impact factor: 3.996

Review 3.  Applications of stem cell biology to oculoplastic surgery.

Authors:  Michael G Daniel; Albert Y Wu
Journal:  Curr Opin Ophthalmol       Date:  2016-09       Impact factor: 3.761

4.  Osmoregulation of taurine transporter function and expression in retinal pigment epithelial, ganglion, and müller cells.

Authors:  Amira El-Sherbeny; Hany Naggar; Seiji Miyauchi; M Shamsul Ola; Dennis M Maddox; Pamela Moore Martin; Vadivel Ganapathy; Sylvia B Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-02       Impact factor: 4.799

5.  Cell response to oxidative stress induced apoptosis in patients with Leber's hereditary optic neuropathy.

Authors:  C Battisti; P Formichi; E Cardaioli; S Bianchi; P Mangiavacchi; S A Tripodi; P Tosi; A Federico
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-12       Impact factor: 10.154

Review 6.  Magnetic resonance in studies of glaucoma.

Authors:  Michal Fiedorowicz; Wojciech Dyda; Robert Rejdak; Pawel Grieb
Journal:  Med Sci Monit       Date:  2011-10

7.  Both systemic and local application of granulocyte-colony stimulating factor (G-CSF) is neuroprotective after retinal ganglion cell axotomy.

Authors:  Tobias Frank; Johannes C M Schlachetzki; Bettina Göricke; Katrin Meuer; Gundula Rohde; Gunnar P H Dietz; Mathias Bähr; Armin Schneider; Jochen H Weishaupt
Journal:  BMC Neurosci       Date:  2009-05-14       Impact factor: 3.288

8.  One-step isolation of sappanol and brazilin from Caesalpinia sappan and their effects on oxidative stress-induced retinal death.

Authors:  Golam Mezbah Uddin; Chul Young Kim; Donghwa Chung; Kyung-A Kim; Sang Hoon Jung
Journal:  BMB Rep       Date:  2015-05       Impact factor: 4.778

Review 9.  Using stem cell biology to study and treat ophthalmologic and oculoplastic diseases.

Authors:  Albert Y Wu; Michael G Daniel
Journal:  Taiwan J Ophthalmol       Date:  2017 Apr-Jun

10.  Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease.

Authors:  Benjamin M Davis; Milena Pahlitzsch; Li Guo; Shiama Balendra; Parth Shah; Nivedita Ravindran; Giulia Malaguarnera; Claudia Sisa; Ehtesham Shamsher; Hisham Hamze; Abdinasir Noor; Acom Sornsute; Satyanarayana Somavarapu; M Francesca Cordeiro
Journal:  Sci Rep       Date:  2018-07-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.